BioStent Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$16M
BioStent General Information
Description
Developer of a medical device intended to protect from coronary artery diseases. The company's device helps the restoration of blood flow in patients with bioerodible vascular stent, enabling patients to get faster relief from coronary artery diseases.
Contact Information
Corporate Office
- 2180 Sand Hill Road
- Menlo Park, CA 94025
- United States
Corporate Office
- 2180 Sand Hill Road
- Menlo Park, CA 94025
- United States
BioStent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 20-Apr-2004 | $16M | Completed | Startup | ||
| 1. Early Stage VC | Completed | Startup |
BioStent Patents
BioStent Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003287916-A1 | A system and apparatus for removal of unwanted substances in a gas flow | Inactive | 18-Dec-2002 | ||
| WO-2004054688-A1 | A system and apparatus for removal of unwanted substances in a gas flow | Inactive | 18-Dec-2002 |
BioStent Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delphi Ventures (California) | Venture Capital | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| Saints Capital | Secondary Buyer | Minority | ||
| Synecor | Corporation | Minority |
BioStent FAQs
-
When was BioStent founded?
BioStent was founded in 2002.
-
Where is BioStent headquartered?
BioStent is headquartered in Menlo Park, CA.
-
What industry is BioStent in?
BioStent’s primary industry is Surgical Devices.
-
Is BioStent a private or public company?
BioStent is a Private company.
-
What is the current valuation of BioStent?
The current valuation of BioStent is .
-
What is BioStent’s current revenue?
The current revenue for BioStent is .
-
Who are BioStent’s investors?
Delphi Ventures (California), Frazier Healthcare Partners, Saints Capital, and Synecor have invested in BioStent.
-
When was BioStent acquired?
BioStent was acquired on 20-Apr-2004.
-
Who acquired BioStent?
BioStent was acquired by Guidant.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process